API Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (Websockets) API Financial News API Delisted Data API
Solutions
New & Popular APIs
Show all APIs Fundamental Data APIs Historical End-of-Day API Financial Events & News API Indices Historical Constituents API 40 000 Stock Market Logos API Forex Data APIs
Other products
Google Sheets Add-on Excel Add-on Coding Libraries (Python, R, etc) Wordpress Add-on
API Marketplace
Community
Academy 152 articles Forum Github 14 repos
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NEO /
  3. FH.NEO

Filament Health Corp (FH NEO) stock market data APIs

C$0.04 0.01(33.3%) as of October 21, 2024
Price chart is built with Anychart

Filament Health Corp. operates as a clinical-stage natural psychedelic drug development company in Canada. Its leading drug candidates comprises PEX010 oral psilocybin, PEX020 oral psilocin, and PEX030 sublingual psilocin. The company also develops AEX010 ayahuasca, which is in preclinical stage; and AEX020 monoamine oxidase inhibitor and is in preclinical stage. In addition, it provides in-house human clinical trials, as well as license technology to drug developers, researchers, and other licensed parties. Filament Health Corp. is headquartered in Burnaby, Canada.

Filament Health Corp Financial Data Overview

0.03
0.04
-
0.04
0.03
0.03-0.2
9 163 K
262 M
2 476 K
-0.07
1.028
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'FH',
Type: 'Common Stock',
Name: 'Filament Health Corp',
Exchange: 'NEO',
CurrencyCode: 'CAD',
CurrencyName: 'Canadian Dollar',
CurrencySymbol: 'C$',
CountryName: 'Canada',
CountryISO: 'CA',
OpenFigi: NULL,
ISIN: 'CA31685W1068',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Drug Manufacturers - Specialty & Generic',
}

Filament Health Corp Fundamental Data is available in our Financial Data APIs

  • Net Revenue 2 476 K
  • EBITDA -3 645 664
  • Earnings Per Share -0.02
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Filament Health Corp Earnings via APIs

  • Latest Release 2023-03-31
  • EPS/Forecast -0.02

Get Filament Health Corp End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Filament Health Corp latest news via APIs

PharmAla Biotech and Filament Health Announce Release of Second Batch of GMP MDMA Capsules

VANCOUVER, British Columbia, Nov. 15, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”) (CSE:MDMA)(OTCQB:PMBHF), a Canadian biotechnology company dedicated to the research and...
  • API
  • AUSTRALIA
  • CANADIAN STOCK EXCHANGE:MDMA.CN
  • CLINICAL TRIALS
  • CONFERENCE CALLS/ WEBCASTS
  • DRUG DEVELOPMENT
  • DRUG PRODUCT
  • HEALTH
  • MDMA
  • PARTNERSHIPS
  • PHARMALA BIOTECH
  • PSYCHEDELICS

PharmAla Biotech and Filament Health Announce Release of GMP MDMA Capsules

VANCOUVER, British Columbia, April 11, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”) (CSE:MDMA), a Canadian biotechnology company dedicated to the research and development...
  • BIOTECH
  • CANADIAN STOCK EXCHANGE:MDMA.CN
  • CLINICAL
  • DRUG
  • DRUG DEVELOPMENT
  • HEALTH
  • MDMA
  • PARTNERSHIPS
  • PHARMALA BIOTECH
  • PRODUCT / SERVICES ANNOUNCEMENT
  • SPECIAL ACCESS
  • TRIALS
News API is available at any package from $19.99 See full price
Get sample of News API
Do you have any questions?
support@eodhistoricaldata.com